Risk factors for motor response complications in L-dopa-treated parkinsonian patients
Peppe, A.; Dambrosia, J.M.; Chase, T.N.
Advances in Neurology 60: 698-702
1993
ISSN/ISBN: 0091-3952 PMID: 8420213 Document Number: 405740
Document emailed within 1 workday
Related Documents
Indo, T.; Takahashi, A. 1987: Should L-dopa therapy for Parkinson's disease be started early or late? Clinical course of the major tetrad in 122 Parkinsonian patients treated with L-dopa over 14 years Rinsho Shinkeigaku 27(11): 1419-1422Ransmayr, G.; Künig, G.; Neubauer, M.; Wagner, M.; Bösch, S.; Kreczy-Kleedorfer, B. 1993: Is the decreasing responsiveness of axial motor symptoms to L-dopa in elderly parkinsonian patients related to age-associated nonparkinsonian pathologies? Advances in Neurology 60: 685-689
Gersten, J.W.; Marshall, C.; Dillon, T.; Schneck, S.A.; Orr, W.; Nelson, C. 1972: External work of walking and functional capacity in Parkinsonian patients treated with L-dopa Archives of Physical Medicine and Rehabilitation 53(12): 547-553
Geissbuhler, F.; Eisenring, J.J.; Friedli, P.; Bartholini, G.; Tissot, R. 1972: Cerebral and peripheral L-dopa uptake in patients with parkinsonian, depressive or manic syndromes administered L-dopa by perfusion combined or not with a decarboxylase inhibitor. Pharmacological effects L'Encephale 61(2): 127-148
Chase, T.N.; Oh, J.D. 2000: Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications Annals of Neurology 47(4 Suppl 1): S122
Ambrosetto, C.; Martinelli, P. 1971: Clinical considerations on therapy of parkinsonian syndromes with amantadine and L-Dopa Minerva Medica 62(82): 4017-4019
Ciuca, I.; Bulandra, R.; Serbanesco, L.; Ninosu, N. 1972: Comparative value of L-dopa, amantadine, anticholinergics, and their combinations in parkinsonian syndromes Revue Neurologique (Paris) 127(2): 305-308
Fischer, P.A. 1974: Therapy of Parkinsonian syndrome using L-dopa. Current state and problems Der Nervenarzt 45(12): 617-627
Blaim, A.; Kulesza, B. 1980: Changes in the response of the hypothalamo-hypophyseal system to TRH and TRH and L-dopa in primary congenital hypothyroidism in children treated with desiccated thyroid Endokrynologia Polska 31(2): 125-131
Horiguchi, J.; Inami, Y.; Miyoshi, N.; Kakimoto, Y. 1985: Restless legs syndrome in four parkinsonian patients treated with amantadine Rinsho Shinkeigaku 25(2): 153-156
Muenter, M.D.; Tyce, G.M. 1971: L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects Mayo Clinic Proceedings 46(4): 231-239
Itoh, S.; Uchiyama, H.; Kawanaka, H.; Higashi, T.; Egashira, A.; Eguchi, D.; Okuyama, T.; Tateishi, M.; Korenaga, D.; Takenaka, K. 2014: Characteristic risk factors in cirrhotic patients for posthepatectomy complications: comparison with noncirrhotic patients American Surgeon 80(2): 166-170
Del Dotto, P.; Colzi, A.; Pardini, C.; Lucetti, C.; Dubini, A.; Grimaldi, R.; Bonuccelli, U. 1995: Cabergoline improves motor disability without modifying L-dopa plasma levels in fluctuating Parkinson's disease patients Journal of Neural Transmission. Supplementum 45: 259-265
Quattrini, A.; Paggi, A.; Forastieri, L.; Del Pesce, M.; Di Bella, P. 1979: Efficacy and side-effects of long term L-dopa therapy in Parkinsonian syndromes (evaluated by CT scan as well) Rivista di Patologia Nervosa e Mentale 99(5): 289-297
Fihn, S.D.; Callahan, C.M.; Martin, D.C.; McDonell, M.B.; Henikoff, J.G.; White, R.H. 1996: The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics Annals of Internal Medicine 124(11): 970-979
Ginath, Y.; Lavy, S.; Abramsky, O.; Carmon, A. 1971: Mental complications of L-dopa therapy in Parkinson's patients Israel Annals of Psychiatry and Related Disciplines 9(3): 252-264
Rabadeau Dumas, J.L.; Rondot, P.; Cardon, P. 1977: Development of studies on the treatment of parkinsonian syndromes with levodopa. II. Long-term effects of L-DOPA alone or in combination with a decarboxylase inhibitor Therapie 32(2): 161-172
Kozek, E.; Górska, A.; Fross, K.; Marcinowska, A.; Citkowska, A.; Sieradzki, J. 2003: Chronic complications and risk factors in patients with type 1 diabetes mellitus--retrospective analysis Przeglad Lekarski 60(12): 773-777
Kutyrina, I.M.; Rudenko, T.E.; Shvetsov, M.Iu.; Kushnir, V.V. 2006: Risk factors of vascular complications in patients at a predialysis stage of chronic renal failure Terapevticheskii Arkhiv 78(5): 45-50
Príbelský, M.; Porubský, J.; Schnorrer, M. 1996: The effect of age and risk factors on postoperative complications and mortality in patients with surgery for colorectal carcinoma Bratislavske Lekarske Listy 97(1): 50-53